International Assets Investment Management LLC Sells 24,069 Shares of Oncolytics Biotech Inc. (NASDAQ:ONCY)

International Assets Investment Management LLC lowered its position in shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) by 12.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 174,331 shares of the company’s stock after selling 24,069 shares during the quarter. International Assets Investment Management LLC owned approximately 0.23% of Oncolytics Biotech worth $152,000 at the end of the most recent quarter.

Separately, Virtu Financial LLC bought a new position in Oncolytics Biotech in the 1st quarter valued at $55,000. Institutional investors and hedge funds own 6.82% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “buy” rating and set a $5.00 target price on shares of Oncolytics Biotech in a report on Thursday, September 19th.

Oncolytics Biotech Trading Down 4.5 %

Shares of ONCY stock opened at $1.07 on Friday. Oncolytics Biotech Inc. has a 1 year low of $0.84 and a 1 year high of $1.75. The firm’s 50 day moving average is $1.08 and its 200-day moving average is $1.06. The firm has a market capitalization of $82.46 million, a price-to-earnings ratio of -3.82 and a beta of 1.69.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.